Pages that link to "Q37249869"

The following pages link to Efficacy and safety of recombinant activated factor VII to control bleeding in nonhemophiliac patients: a review of 17 randomized controlled trials. (Q37249869):

Displaying 11 items.

• Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (Q24236583) (← links)
• Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (Q24245204) (← links)
• Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records (Q33571590) (← links)
• Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B. (Q35069871) (← links)
• Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer (Q35107082) (← links)
• Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery (Q37278551) (← links)
• The contemporary role of blood products and components used in trauma resuscitation (Q37812157) (← links)
• Update on Blood Conservation for Cardiac Surgery (Q37946028) (← links)
• Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal (Q38127582) (← links)
• [Management of massive bleeding in 2013: seven questions and answers] (Q86597848) (← links)
• Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC) (Q90399079) (← links)